Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma

Verfasser / Beitragende:
[Cindrilla Chumduri, Bernhard Gillissen, Anja Richter, Antje Richter, Ana Milojkovic, Tim Overkamp, Anja Müller, Christiane Pott, Peter Daniel]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Molecular Medicine, 93/5(2015-05-01), 559-572
Format:
Artikel (online)
ID: 605543801
LEADER caa a22 4500
001 605543801
003 CHVBK
005 20210128100928.0
007 cr unu---uuuuu
008 210128e20150501xx s 000 0 eng
024 7 0 |a 10.1007/s00109-014-1242-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00109-014-1242-2 
245 0 0 |a Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma  |h [Elektronische Daten]  |c [Cindrilla Chumduri, Bernhard Gillissen, Anja Richter, Antje Richter, Ana Milojkovic, Tim Overkamp, Anja Müller, Christiane Pott, Peter Daniel] 
540 |a Springer-Verlag Berlin Heidelberg, 2014 
690 7 |a Mitotic catastrophe  |2 nationallicence 
690 7 |a Aneuploidy  |2 nationallicence 
690 7 |a Apoptosis  |2 nationallicence 
690 7 |a Bax  |2 nationallicence 
690 7 |a Bak  |2 nationallicence 
690 7 |a Caspase  |2 nationallicence 
700 1 |a Chumduri  |D Cindrilla  |u Clinical and Molecular Oncology, University Medical Center Charité and Max-Delbrück-Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin-Buch, Germany  |4 aut 
700 1 |a Gillissen  |D Bernhard  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
700 1 |a Richter  |D Anja  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
700 1 |a Richter  |D Antje  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
700 1 |a Milojkovic  |D Ana  |u Clinical and Molecular Oncology, University Medical Center Charité and Max-Delbrück-Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin-Buch, Germany  |4 aut 
700 1 |a Overkamp  |D Tim  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
700 1 |a Müller  |D Anja  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
700 1 |a Pott  |D Christiane  |u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian-Albrechts University, Campus Kiel, 24116, Kiel, Germany  |4 aut 
700 1 |a Daniel  |D Peter  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
773 0 |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/5(2015-05-01), 559-572  |x 0946-2716  |q 93:5<559  |1 2015  |2 93  |o 109 
856 4 0 |u https://doi.org/10.1007/s00109-014-1242-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00109-014-1242-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chumduri  |D Cindrilla  |u Clinical and Molecular Oncology, University Medical Center Charité and Max-Delbrück-Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin-Buch, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Gillissen  |D Bernhard  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Richter  |D Anja  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Richter  |D Antje  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Milojkovic  |D Ana  |u Clinical and Molecular Oncology, University Medical Center Charité and Max-Delbrück-Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin-Buch, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Overkamp  |D Tim  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Müller  |D Anja  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pott  |D Christiane  |u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Christian-Albrechts University, Campus Kiel, 24116, Kiel, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Daniel  |D Peter  |u Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University, 13353, Berlin, Germany  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Molecular Medicine  |d Springer Berlin Heidelberg  |g 93/5(2015-05-01), 559-572  |x 0946-2716  |q 93:5<559  |1 2015  |2 93  |o 109